Nurix Therapeutics Inc to Discuss Data Presented at ASH Transcript
Good evening everyone. My name is Arthur Sands. I'm President and CEO of Nex Therapeutics.
And I'd like to welcome you to our 2025 investor and analyst event, broadcasting, here from Orlando, Florida after, well, still in the midst of a terrific Ash but getting near the end, but a lot of exciting, new information at Ash this year.
Not only for our programs but many others that are relevant to the incredible opportunities to improve therapies for patients, with CLL and many other diseases covered here. So really absolutely terrific, meeting.
So we're very excited to have you all, tonight, and, I'll be making a few opening remarks and then we're going to dive, do a deep dive into our data that was presented here today. We're very fortunate. To have, Doctor Alan Carr here from University of Miami who will be presenting the data, a fantastic, expert, in the field, one of our key investigators, we're very excited to have you.
Thank you, Doctor Alan Carr, and then we'll have our Chief
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
